866-997-4948(US-Canada Toll Free)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Switzerland

Published By :

GlobalData

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 124 Pages

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Switzerland

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Switzerland". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Switzerland. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Switzerland. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

High expenditure on pharmaceutical R&D and the presence of major pharmaceutical companies has propelled the growth of the Swiss healthcare industry. It spends approximately 11.65% of its GDP on healthcare. In 2015 pharmaceutical sales increased to $6.4 billion from $5.5 billion in 2010. The market is forecast to grow to $8.0 billion in 2022; at a CAGR of 3%. In 2010, the medical device market in Switzerland was worth $2.4 billion, which increased to $3.1 billion in 2017. The main segments were in vitro diagnostics, cardiovascular devices, nephrology and urology devices, orthopedic devices and healthcare IT. The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Switzerland, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Octapharma, Basilea, Actelion, Novartis and Roche) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostics, DePuy Synthes, Agfa and Coloplast)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Switzerland
- Porters five forces analysis for pharmaceutical and medical devices market of Switzerland
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Swiss healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Swiss healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Swiss healthcare market.
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Pharmaceutical Market, Distribution Channels, Switzerland, 2016 19
Table 2: Pharmaceutical Market, Switzerland, Self Medication Product Category Sales ($m), 2016 20
Table 3: Pharmaceutical Market, Switzerland, Major therapeutic groups based on drug sales ($m), 2015 21
Table 4: Medical Device Market, Switzerland, Revenue by Segment ($m) and share (%), 2017 40
Table 5: IVD Devices Market, Switzerland, Revenue ($m) and Market Share (%) of Major Companies, 2017 41
Table 6: Cardiovascular Devices Market, Switzerland, Revenue ($m) and Market Share (%) of Major Companies, 2017 42
Table 7: Nephrology and Urology Devices Market, Switzerland, Revenue ($m) and Market Share (%) of Major Companies, 2016 43
Table 8: Orthopedic Devices Market, Switzerland, Revenue ($m) and Market Share (%) of Major Companies, 2016 44
Table 9: Healthcare IT Market, Switzerland, Revenue ($m) and Market Share (%) of Major Companies, 2015 45
Table 10: Fees for Market Authorization Procedure, Switzerland, 2018 82
Table 11: Patent Fees, Switzerland, 2018 91
Table 12: Trademark Fees, Switzerland, 2018 93
Table 13: Clinical Trial Process Fees, Switzerland, 2018 94
Table 14: Trade Fairs, Switzerland 108

List of Figures
Figure 1: Pharmaceutical Market, Switzerland, Revenue ($bn), 2010-2017 8
Figure 2: Medical Device Market, Switzerland, Revenue ($bn), 2010-2017 8
Figure 3: Country Profile, Switzerland, 2018 14
Figure 4: Pharmaceutical Market, Switzerland, Revenue ($bn), 2010-2017 16
Figure 5: Pharmaceutical Market, Switzerland, Revenue Forecast ($bn), 2018-2022 16
Figure 6: Pharmaceutical Exports ($bn), Switzerland, 2010-2017 17
Figure 7: Top Export Partners, Switzerland, 2017 17
Figure 8: Pharmaceutical Imports ($bn), Switzerland, 2010-2017 18
Figure 9: Top Import Partners, Switzerland, 2017 18
Figure 10: Distribution Channels, Switzerland 19
Figure 11: Pharmaceutical Market, Switzerland, Major therapeutic groups based on drug sales ($m), 2015 21
Figure 12: Pharmaceutical Market, Switzerland, Major Players 23
Figure 13: Medical Device Market, Switzerland, Revenue ($bn), 2010-2017 39
Figure 14: Medical Device Market, Switzerland, Revenue Forecast ($bn), 2018-2022 39
Figure 15: Medical Device Market, Switzerland, Revenue by Segment ($m), 2017 40
Figure 16: IVD Devices Market, Switzerland, Revenue ($m), 2010-2017 41
Figure 17: IVD Devices Market, Switzerland, Market Share of Major Players (%), 2017 41
Figure 18: Cardiovascular Devices Market, Switzerland, Revenue ($m), 2010-2017 42
Figure 19: Cardiovascular Devices Market, Switzerland, Market Share of Major Players (%), 2017 42
Figure 20: Nephrology and Urology Devices Market, Switzerland, Revenue ($m), 2010-2017 43
Figure 21: Nephrology and Urology Devices Market, Switzerland, Market Share of Major Players (%), 2016 43
Figure 22: Orthopedic Devices Market, Switzerland, Revenue ($m), 2010-2017 44
Figure 23: Orthopedic Devices Market, Switzerland, Market Share of Major Players (%), 2016 44
Figure 24: Healthcare IT Market, Switzerland, Revenue ($m), 2010-2017 45
Figure 25: Healthcare IT Market, Switzerland, Market Share of Major Companies (%), 2015 45
Figure 26: Diagnostic Market, Switzerland, Revenue ($bn), 2010-2017 46
Figure 27: Diagnostic Market, Switzerland, Revenue ($bn), 2018-2022 46
Figure 28: Medical Device Market, Switzerland, Revenue ($bn) of Major Companies, 2016 48
Figure 29: Deal Value and Deal Count, Pharmaceutical Market, Switzerland, 2017-2018 68
Figure 30: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Switzerland, 2017-2018 68
Figure 31:Deal Value and Deal Count Sub-types, Pharmaceutical Market, Switzerland, 2017-2018 68
Figure 32: Top 5 therapy area by deal value, Pharmaceutical Market, Switzerland, 2017-2018 69
Figure 33: Top 5 therapy area by deal number, Pharmaceutical Market, Switzerland, 2017-2018 69
Figure 34: M&A deals by therapy area, Pharmaceutical Market, Switzerland, 2017-2018 (By value and by number) 69
Figure 35: Venture Financing deals by therapy area, Pharmaceutical Market, Switzerland, 2017-2018 (By value and by number) 69
Figure 36: Private Equity deals by therapy area, Pharmaceutical Market Switzerland, 2017-2018 (By value and by number) 69
Figure 37:Medical Device Market Deals (by deal value, $m), Switzerland, 2017-2018 70
Figure 38:Medical Device Market Deals (by deal count), Switzerland, 2017-2018 70
Figure 39: Medical Device Market Deals Share (by deal count), Switzerland, 2017-2018 70
Figure 40: Medical Device Market Deals Share (by deal value), Switzerland, 2017-2018 70
Figure 41: Medical Device, Switzerland, Top Therapy Area by Deal Value, 2017-2018 71
Figure 42: Medical Devices, Switzerland, Top Therapy Area by Deal Number, 2017-2018 71
Figure 43: Medical Devices, Switzerland, M&A Deals by Therapy Area, 2017-2018 71
Figure 44: Medical Devices, Switzerland, VF Deals by Therapy Area, 2017-2018 71
Figure 45: Medical Devices, Switzerland, Private Equity Deals by Therapy Area, 2017-2018 71
Figure 46: Overview of Healthcare System, Switzerland, 2015 76
Figure 47: Drug Reimbursement Process, Switzerland, 2017 77
Figure 48: Out-of-Pocket Expenditure (% of total expenditure on health), Switzerland, 2010-2017 79
Figure 49: Change in Price Trend in Drug Sector (%), Switzerland, 2010-2017 79
Figure 50: Swissmedic, Organizational structure, Switzerland, 2018 81
Figure 51: Market Authorization Procedure, Switzerland, 2018 83
Figure 52: Conformity Assessment of Class I Medical Devices, EU, 2018 85
Figure 53: Conformity Assessment of Class IIa Medical Devices, EU, 2018 86
Figure 54: Conformity Assessment of Class IIb Medical Devices, EU, 2018 87
Figure 55: Conformity Assessment of Class III Medical Devices, EU, 2018 88
Figure 56: National Patent Approval Process, Switzerland, 2018 91
Figure 57: European Patent Approval Process, EU, 2018 92
Figure 58: National Trademark Approval Process, Switzerland, 2018 93
Figure 59: Clinical Trial Regulation Process, Switzerland, 2018 94
Figure 60: Labelling and Packaging Regulations, Switzerland, 2018 97
Figure 61: Hospitals (Number), Switzerland, 2010-2017 100
Figure 62: Hospital Bed by Type of Care (Number), Switzerland, 2010-2017 100
Figure 63: Diagnostic Equipment (Number), Switzerland, 2010-2017 100
Figure 64: Hospital Beds (per 1,000 population), Switzerland, 2010 - 2017 101
Figure 65: Life Expectancy (years), Switzerland, 2010-2017 101
Figure 66: Immunization Rate (%), Switzerland, 2010-2017 101
Figure 67: Major Causes of Mortality, No. of deaths (000), Switzerland, 2012 102
Figure 68: Major Causes of Male Mortality, No. of deaths (000), Switzerland, 2015 102
Figure 69: Major Causes of Female Mortality, No. of deaths (000), Switzerland, 2015 102
Figure 70: Disability-Adjusted Life Years by Major Disease (000), Switzerland, 2015 102
Figure 71: Physicians (per 1,000 population), Switzerland, 2010-2017 103
Figure 72: Nurses (per 1,000 population), Switzerland, 2010-2017 103
Figure 73: Dentists, (per 1,000 population), Switzerland, 2010-2017 103
Figure 74: Pharmacists, (per 1,000 population), Switzerland, 2010-2017 103
Figure 75: PM2.5 (g per m3), Switzerland, 2010-2017 104
Figure 76: CO2 Emissions (k tons), Switzerland, 2010-2017 104
Figure 77: Healthcare Expenditure (% of GDP), Switzerland, 2010-2017 105
Figure 78: Public-Private Share (%), Switzerland, 2010-2017 105
Figure 79: Major Components of Healthcare Spending (%), Switzerland, 2011 106
Figure 80: Spending in R&D by sector (share %), Switzerland, 2015 106
Figure 81: Trade Associations, Switzerland 107
Figure 82: Opportunities & Challenges, Switzerland 110

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *